Indeed, the frequency of BAP1 loss was significantly higher in intrahepatic cholangiocarcinoma when compared to extrahepatic cholangiocarcinoma and pancreatic carcinoma. The gene discussed is BAP1; the disease is exocrine pancreatic carcinoma.